As per DelveInsight’s assessment, The drug delivery devices market is largely driven by the rising prevalence of chronic diseases, increasing demand for self-administration and home-based care, greater adoption of biologics and biosimilars, ongoing technological advancements, and heightened product development initiatives by leading market players.
DelveInsight's “Drug Delivery Devices Market Insights, Competitive Landscape, and Market Forecast - 2032” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Drug Delivery Devices companies actively working in the market.
Explore the future of healthcare innovation with our comprehensive Drug Delivery Devices Market Forecast. Stay ahead in the industry!
https://www.delveinsight.com/report-store/drug-delivery-devices-market
Drug Delivery Devices Overview
Drug delivery devices are medical tools or systems designed to administer medications into the body in a controlled, safe, and effective manner. They play a crucial role in ensuring the right dose of a drug reaches the targeted site at the right time, improving treatment outcomes and patient compliance.
These devices are used across various routes of administration, including oral, injectable, inhalation, transdermal, and implantable systems. Common examples include syringes, insulin pens, inhalers, infusion pumps, transdermal patches, and auto-injectors.
Drug Delivery Devices Market Insights
The drug delivery devices market is experiencing strong growth due to several key factors. The increasing prevalence of chronic diseases is driving the need for long-term and accurate medication management, while the rising preference for self-administration and home-based care is boosting demand for convenient and user-friendly devices. Additionally, the growing use of biologics and biosimilars often requiring specialized delivery systems is expanding the scope for advanced technologies. Ongoing technological innovations, including smart and connected devices, along with continuous product development by major market players, are further propelling market expansion.
DelveInsight Analysis: The global drug delivery devices market size is projected to grow from USD 492.13 billion in 2024 to USD 760.98 billion by 2032, expanding at a CAGR of 5.66% during the forecast period from 2025 to 2032.
To know more about why North America is leading the market growth in the Drug Delivery Devices market, get a snapshot of the report Drug Delivery Devices Market Trends
Recent Developments in the Drug Delivery Devices Market Report
-
In August 2025, argenx SE announced that the U.S. FDA approved a new prefilled syringe option for patients to self-inject VYVGART® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc). This approval was for treating adult patients with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive, and for adults with chronic inflammatory demyelinating polyneuropathy (CIDP).
-
In August 2025, the FDA approved Leqembi IQLIK (Eisai‑Biogen), a weekly subcutaneous prefilled autoinjector for Alzheimer’s disease maintenance therapy.
-
In May 2025, the FDA designated HADLIMA™ (adalimumab-bwwd) autoinjectors and high-concentration prefilled syringes as interchangeable biosimilars to Humira®, making it interchangeable with all Humira® presentations.
-
In May 2025, the UK Medicines and Healthcare Products Regulatory Agency (MHRA) approved AstraZeneca's low-carbon Trixeo Aerosphere inhaler, the world’s first environmentally friendly inhaler for moderate-to-severe COPD.
-
In February 2024, Sequel Twist AID System received FDA approval. The twist AID is the first automated insulin delivery (AID) system to directly measure insulin delivery volume and flow, enabling rapid detection of obstructions.
-
In January 2023, PharmaSens, a Switzerland-based company specializing in medical devices, applied for FDA approval in the United States for its 'niia essential' insulin patch pump system.
Key Players in the Drug Delivery Devices Market
Some of the key market players operating in the Drug Delivery Devices market include- Pfizer, Inc., Johnson & Johnson Services, Inc, F. Hoffmann-La Roche, Ltd., Novartis AG, 3M, Bayer AG, GlaxoSmithKline plc., AstraZeneca PLC, Becton Dickinson, Boehringer Ingelheim group, Insulet Corporation, Medtronic, West Pharmaceuticals Services, Inc., Generex Biotechnology, Panacea Pharmaceuticals Inc., Aptar Pharma, Koninklijke Philips N.V., Biocorp Production., Terumo Corporation, Eli Lilly and Co, and others.
To read more about the latest highlights related to Drug Delivery Devices, get a snapshot of the key highlights entailed in the Drug Delivery Devices Market Forecast Report
Market Analysis on the Drug Delivery Devices Market
According to estimates, North America is anticipated to lead the drug delivery devices market, driven by the high incidence of chronic conditions such as diabetes, cancer, and respiratory diseases, along with well-established healthcare infrastructure and strong uptake of advanced technologies. The region also benefits from substantial R&D investments, supportive regulatory frameworks, and the presence of key industry players. Moreover, increasing demand for self-administration devices and home-based healthcare solutions is further boosting market growth across the United States and Canada.
The drug delivery devices market features a moderately concentrated competitive landscape, with major players such as West Pharmaceutical Services, Gerresheimer AG, Becton Dickinson, and Baxter International commanding substantial market shares through their robust product portfolios, regulatory expertise, and extensive manufacturing capabilities. At the same time, mid-sized companies are strengthening their presence by focusing on niche innovations like microneedle patches, needle-free injectors, and digital adherence solutions. Furthermore, pharmaceutical firms are increasingly adopting vertical integration strategies to gain greater control over biologics delivery, as illustrated by Novo Nordisk’s acquisition of Catalent’s manufacturing facilities.
Scope of the Drug Delivery Devices Market Report
-
Coverage: Global
-
Study Period: 2022–2032
-
Drug Delivery Devices Market Segmentation By Debice Type: Implantable Devices [Drug Infusion Pumps, Implantable Stents, and Others], Injectable Devices, Inhalers and Nebulizers, Transdermal Patches, and others
-
Drug Delivery Devices Market Segmentation By Route of Administration: Inhalation, Transdermal, Implantable, Parenteral (Injection) [Subcutaneous, Intramuscular, and Intravenous], and others
-
Drug Delivery Devices Market Segmentation By Application: Oncology, Infectious Diseases, Respiratory Diseases, Autoimmune Diseases, Cardiovascular Diseases, and others
-
Drug Delivery Devices Market Segmentation By End Users: Hospitals, Specialty Clinics, and Ambulatory Surgical Centers
-
Drug Delivery Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
-
Key Drug Delivery Devices Companies: Pfizer, Inc., Johnson & Johnson Services, Inc, F. Hoffmann-La Roche, Ltd., Novartis AG, 3M, Bayer AG, GlaxoSmithKline plc., AstraZeneca PLC, Becton Dickinson, Boehringer Ingelheim group, Insulet Corporation, Medtronic, West Pharmaceuticals Services, Inc., Generex Biotechnology, Panacea Pharmaceuticals Inc., Aptar Pharma, Koninklijke Philips N.V., Biocorp Production., Terumo Corporation, Eli Lilly and Co, and others
-
Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
Which MedTech key players in the Drug Delivery Devices market are set to emerge as the trendsetter explore @ Drug Delivery Devices Manufacturer
Table of Contents
| 1 | Drug Delivery Devices Market Report Introduction |
| 2 | Drug Delivery Devices Market Executive summary |
| 3 | Regulatory and Patent Analysis |
| 4 | Drug Delivery Devices Market Key Factors Analysis |
| 5 | Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on Drug Delivery Devices Market |
| 7 | Drug Delivery Devices Market Layout |
| 8 | Global Company Share Analysis – Key 3-5 Companies |
| 9 | Company and Product Profiles |
| 10 | Drug Delivery Devices Market Drivers |
| 11. | Drug Delivery Devices Market Barriers |
| 12. | Project Approach |
| 13. | About DelveInsight |
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email:Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
